EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Field efficacy of a combined use of Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae vaccines in growing pigs



Field efficacy of a combined use of Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae vaccines in growing pigs



Preventive Veterinary Medicine 39(1): 13-24



The effectiveness of simultaneous administration of commercial Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae vaccines was tested in an indoor commercial piggery which had experienced continuing respiratory-disease problems confirmed as due to both of these pathogens. Piglets were randomly assigned in equal numbers to vaccination and control groups, and each vaccine was administered at a separate site to assigned piglets at two and four weeks of age. Live weight of vaccinates immediately prior to slaughter was 2.49 kg higher (p = 0.04) than for controls at equal mean slaughter age of 132 days. Average daily gain (ADG) from 16 weeks to slaughter of vaccinates was also significantly higher (33 g/day) than in controls (p = 0.05). Daily gain was not significantly different in younger age groups. Active enzootic pneumonia lesions were more likely in control than in vaccinated pigs. There were no significant differences between vaccination groups with regard to severity of pleurisy or presence of pleuropneumonia lesions at slaughter. Log-linear modelling was used to test the statistical association between vaccination, enzootic pneumonia lesions, pleurisy lesions and pleuropneumonia lesions. It showed a reduction in the severity of enzootic pneumonia lesions for vaccinated pigs, and the presence of pleuropneumonia lesions increased the likelihood of pleurisy lesions. No other association was significant, and no evidence of synergy between the vaccines in influencing lesion severity for pleuropneumonia was detected (within the limitations set by the trial design).

Accession: 003141006

Download citation: RISBibTeXText

PMID: 10081785

DOI: 10.1016/s0167-5877(98)00147-0

Download PDF Full Text: Field efficacy of a combined use of Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae vaccines in growing pigs



Related references

Evaluation of serovar-independent ELISA antigens of Actinobacillus pleuropneumoniae in pigs, following experimental challenge with A. pleuropneumoniae, Mycoplasma hyopneumoniae and Pasteurella multocida. Australian Veterinary Journal 90(6): 225-234, 2012

Experimental infection of SPF pigs with Actinobacillus pleuropneumoniae serotype 9 alone or in association with Mycoplasma hyopneumoniae. Veterinary Microbiology 135(3-4): 283-291, 2008

Potential synergism between Aujeszky virus, Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae in fattening pigs. Tecnica Pecuaria en Mexico 37(1): 23-30, 1999

Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Canadian Journal of Veterinary Research 65(4): 213-222, 2001

Treatment of pigs experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida, and Actinobacillus pleuropneumoniae with various antibiotics. Canadian Journal of Veterinary Research 65(4): 213-222, 2002

Study on the efficacy of active immunization against Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae on a large-scale pig farm. Magyar Allatorvosok Lapja 50(10): 787, 1995

Effect of pneumonia on growth rate and feed efficiency of minimal disease pigs exposed to actinobacillus pleuropneumoniae and mycoplasma hyopneumoniae. Preventive Veterinary Medicine 9(4): 287-294, 1990

Incidence of infections in pigs bred for slaughter revealed by elevated serum levels of interferon and development of antibodies to Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae. Zentralblatt für Veterinarmedizin. Reihe B. Journal of Veterinary Medicine. Series B 40(1): 1-12, 1993

Efficacy of Tiamutin + CTC, lincomycin + CTC, Econor + CTC and tilmicosin in treatment of piglets experimentally infected with Mycoplasma hyopneumoniae, Pasteurella multocida and Actinobacillus pleuropneumoniae. Journal of Veterinary Pharmacology & Therapeutics 20(SUPPL 1): 131, 1997

Comparative efficacy of commercial Mycoplasma hyopneumoniae and porcine circovirus 2 (PCV2) vaccines in pigs experimentally infected with M. hyopneumoniae and PCV2. Vaccine 29(17): 3206-3212, 2011

Infections with Mycoplasma hyopneumoniae and Actinobacillus pleuropneumoniae in fattening pigs. Influence of piglet production systems and influence on production parameters. Journal of Veterinary Medicine Series B 46(8): 535-544, 1999

Attenuated Actinobacillus pleuropneumoniae as a bacterial vector for expression of Mycoplasma hyopneumoniae P36 gene. Journal of Gene Medicine 13(4): 221-229, 2011